FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080546489> ?p ?o ?g. }

• W2080546489 endingPage "698" @default.
• W2080546489 startingPage "693" @default.
• W2080546489 abstract "The purpose of this study was to determine the clinical significance of (18)F-FDG PET/CT on initial staging and therapy planning in patients with invasive breast cancer. One hundred and forty-one consecutive, biopsy proven preoperative and 195 postoperative high-risk breast cancer patients who were referred for PET/CT for initial staging were included in this retrospective study. The clinical stage had been determined by conventional imaging modalities prior to the PET/CT scan. Of the 141 examined preoperative patients, 19 had clinical stage I (T1N0), 51 had stage IIA (12 T2N0 and 39 T1N1), 49 had stage IIB (2 T3N0 and 47 T2N1), 12 had stage IIIA (11 T3N1, 1 T2N2), 2 had stage IIIB (2 T4N1) and 8 had stage IV. PET/CT modified the staging for 26% of stage I patients, 29% of stage IIA patients, 46% of stage IIB patients, 58% of stage IIIA patients and 100% of stage IIIB patients. PET/CT scans detected extra-axillary regional lymph nodes in 14 (9.9%) patients and distant metastasis in 41 (29%) patients. PET/CT scans detected multifocal lesions in 30 (21%) patients, multicentric lesions in 21 (14%) patients and malign foci in the contralateral breast (bilateral breast cancer) confirmed by biopsy in 5 (3.5%) patients. Of the examined 195 postoperative patients PET/CT detected axillary lymph nodes in 22 (11%) patients, extra-axillary regional lymph nodes in 21 (10%) patients and distant metastasis in 24 (12%) patients. PET/CT findings altered plans for radiotherapy in 22 (11%) patients and chemotherapy was adapted to the meta-static diseases in 24 (12%) patients. PET/CT was revealed to be superior to conventional imaging modalities for the detection of extra-axillary regional metastatic lymph nodes and distant metastases. These features make PET/CT an essential imaging modality for the primary staging of invasive breast cancer, particularly in patients with clinical stages II and III." @default.
• W2080546489 created "2016-06-24" @default.
• W2080546489 creator A5003480615 @default.
• W2080546489 creator A5022777934 @default.
• W2080546489 creator A5037934812 @default.
• W2080546489 creator A5050142844 @default.
• W2080546489 creator A5050504416 @default.
• W2080546489 creator A5067298860 @default.
• W2080546489 date "2012-08-09" @default.
• W2080546489 modified "2023-10-01" @default.
• W2080546489 title "Clinical impact of 18F-FDG PET/CT on initial staging and therapy planning for breast cancer" @default.
• W2080546489 cites W1606431876 @default.
• W2080546489 cites W1965734230 @default.
• W2080546489 cites W2015544755 @default.
• W2080546489 cites W2028085888 @default.
• W2080546489 cites W2042492846 @default.
• W2080546489 cites W2057887368 @default.
• W2080546489 cites W2060822614 @default.
• W2080546489 cites W2067615159 @default.
• W2080546489 cites W2071751547 @default.
• W2080546489 cites W2085662337 @default.
• W2080546489 cites W2093259344 @default.
• W2080546489 cites W2093806600 @default.
• W2080546489 cites W2099771817 @default.
• W2080546489 cites W2116880557 @default.
• W2080546489 cites W2117921690 @default.
• W2080546489 cites W2146739062 @default.
• W2080546489 cites W2148781450 @default.
• W2080546489 cites W2167109784 @default.
• W2080546489 cites W2168071479 @default.
• W2080546489 cites W2222885112 @default.
• W2080546489 cites W2331430338 @default.
• W2080546489 cites W4366111328 @default.
• W2080546489 doi "https://doi.org/10.3892/etm.2012.659" @default.
• W2080546489 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3501408" @default.
• W2080546489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23170128" @default.
• W2080546489 hasPublicationYear "2012" @default.
• W2080546489 type Work @default.
• W2080546489 sameAs 2080546489 @default.
• W2080546489 citedByCount "11" @default.
• W2080546489 countsByYear W20805464892015 @default.
• W2080546489 countsByYear W20805464892016 @default.
• W2080546489 countsByYear W20805464892017 @default.
• W2080546489 countsByYear W20805464892020 @default.
• W2080546489 countsByYear W20805464892021 @default.
• W2080546489 countsByYear W20805464892023 @default.
• W2080546489 crossrefType "journal-article" @default.
• W2080546489 hasAuthorship W2080546489A5003480615 @default.
• W2080546489 hasAuthorship W2080546489A5022777934 @default.
• W2080546489 hasAuthorship W2080546489A5037934812 @default.
• W2080546489 hasAuthorship W2080546489A5050142844 @default.
• W2080546489 hasAuthorship W2080546489A5050504416 @default.
• W2080546489 hasAuthorship W2080546489A5067298860 @default.
• W2080546489 hasBestOaLocation W20805464891 @default.
• W2080546489 hasConcept C121608353 @default.
• W2080546489 hasConcept C126322002 @default.
• W2080546489 hasConcept C126838900 @default.
• W2080546489 hasConcept C127077266 @default.
• W2080546489 hasConcept C142724271 @default.
• W2080546489 hasConcept C146357865 @default.
• W2080546489 hasConcept C151730666 @default.
• W2080546489 hasConcept C2775842073 @default.
• W2080546489 hasConcept C2775934546 @default.
• W2080546489 hasConcept C2777649267 @default.
• W2080546489 hasConcept C2779013556 @default.
• W2080546489 hasConcept C2779720271 @default.
• W2080546489 hasConcept C2989005 @default.
• W2080546489 hasConcept C509974204 @default.
• W2080546489 hasConcept C530470458 @default.
• W2080546489 hasConcept C71924100 @default.
• W2080546489 hasConcept C86803240 @default.
• W2080546489 hasConceptScore W2080546489C121608353 @default.
• W2080546489 hasConceptScore W2080546489C126322002 @default.
• W2080546489 hasConceptScore W2080546489C126838900 @default.
• W2080546489 hasConceptScore W2080546489C127077266 @default.
• W2080546489 hasConceptScore W2080546489C142724271 @default.
• W2080546489 hasConceptScore W2080546489C146357865 @default.
• W2080546489 hasConceptScore W2080546489C151730666 @default.
• W2080546489 hasConceptScore W2080546489C2775842073 @default.
• W2080546489 hasConceptScore W2080546489C2775934546 @default.
• W2080546489 hasConceptScore W2080546489C2777649267 @default.
• W2080546489 hasConceptScore W2080546489C2779013556 @default.
• W2080546489 hasConceptScore W2080546489C2779720271 @default.
• W2080546489 hasConceptScore W2080546489C2989005 @default.
• W2080546489 hasConceptScore W2080546489C509974204 @default.
• W2080546489 hasConceptScore W2080546489C530470458 @default.
• W2080546489 hasConceptScore W2080546489C71924100 @default.
• W2080546489 hasConceptScore W2080546489C86803240 @default.
• W2080546489 hasIssue "4" @default.
• W2080546489 hasLocation W20805464891 @default.
• W2080546489 hasLocation W20805464892 @default.
• W2080546489 hasLocation W20805464893 @default.
• W2080546489 hasLocation W20805464894 @default.
• W2080546489 hasOpenAccess W2080546489 @default.
• W2080546489 hasPrimaryLocation W20805464891 @default.
• W2080546489 hasRelatedWork W2065320481 @default.
• W2080546489 hasRelatedWork W2073663008 @default.
• W2080546489 hasRelatedWork W2113717013 @default.

• next